-
Data Access Committee for the Centre National de Recherche en Génomique Humaine (CNRGH)
Dac
EGAC00001000723
-
Examination of Engineered LINE-1 Integration Events in HeLa Cells
Study
phs001669
-
RNA-seq from islet differentiation model
Dataset
EGAD00001003807
-
Dedifferentiated Melanoma (2021-02-02)
Dataset
EGAD00001006931
-
Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy
Study
phs003704
-
Fgl2 Regulates FcγRIIB+ CD8+ T Cell Responses during Infection
Study
phs003870
-
Whole-Exome Sequences from Imazighen and non-Imazghen from Algeria
Study
EGAS00001007236
-
Data Access Committee KCL FC
Dac
EGAC00001000386
-
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas
Study
phs001993
-
Methylation profiling of CDS and ES tumor samples
Dataset
EGAD00010002760
-
WGS sequencing of an ES tumor sample
Dataset
EGAD00001015607
-
MCF10A 12h IL6 classical signaling
Dataset
EGAD00010001970
-
MCF10A 24h IL6 classical signaling
Dataset
EGAD00010001963
-
AREP(Association pour la Recherche et l’Enseignement en Pathologie) Data Access Commitee
Dac
EGAC00001001196
-
Exome and transcriptome sequencing of CDS and ES tumor samples
Dataset
EGAD00001015608
-
Genome-wide array data Algeria
Dataset
EGAD00001010900
-
Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks
Study
JGAS000121
-
RNA-seq of Ewing sarcoma tumors (ICGC)
Study
EGAS00001003333
-
Methylation of Ewing sarcoma tumors (ICGC)
Study
EGAS00001002161
-
TB-DAR Whole Genome Sequencing Study
Study
EGAS00001005850
-
Mitochondrial DNA sequencing of iPSC, parental cells, and iPSC derived cardiomyocytes
Study
EGAS00001005560
-
Genome Database of Latvian Population
Dac
EGAC50000000624
-
TB-DAR Genotyping Study
Study
EGAS00001007216
-
Characterization of a human iPSC-derived endocrine pancreas model
Study
EGAS00001001803
-
Anti-TIGIT antibody tiragolumab improves PD-L1 blockade via myeloid and Treg cells
Study
EGAS50000000251